FORENSIC PHARMA Trademark

Trademark Overview


On Tuesday, February 29, 2000, a trademark application was filed for FORENSIC PHARMA with the United States Patent and Trademark Office. The USPTO has given the FORENSIC PHARMA trademark a serial number of 75931688. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, March 25, 2003. This trademark is owned by Genome Therapeutics Corporation. The FORENSIC PHARMA trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:

Chemicals, namely, therapeutic agents in the nature of genomic drugs, polypeptides, proteins and genes for use in the pharmaceutical industry

Therapeutic agents, namely, drugs, polypeptides, deoxyribonucleic acid (DNA), proteins and genes for use in the treatment of human diseases and disorders

Computer software featuring a database used for genetic or protein analysis; computer hardware and computer peripherals

Biotechnology research and development services in the field of genomic research, namely drug development and repositioning; designing clinical trials; genomic sequencing and finishing, single nucleotide polymorphism (SNP) detection and haplotyping, providing genomic, polypeptide and protein information; generating genomes; pharmocogenomics, diagnostics and therapeutics pertaining to disease states and conditions
forensic pharma

General Information


Serial Number75931688
Word MarkFORENSIC PHARMA
Filing DateTuesday, February 29, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, March 25, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 2, 2002

Trademark Statements


Disclaimer with Predetermined Text"FORENSIC"
Goods and ServicesChemicals, namely, therapeutic agents in the nature of genomic drugs, polypeptides, proteins and genes for use in the pharmaceutical industry
Goods and ServicesTherapeutic agents, namely, drugs, polypeptides, deoxyribonucleic acid (DNA), proteins and genes for use in the treatment of human diseases and disorders
Goods and ServicesComputer software featuring a database used for genetic or protein analysis; computer hardware and computer peripherals
Goods and ServicesBiotechnology research and development services in the field of genomic research, namely drug development and repositioning; designing clinical trials; genomic sequencing and finishing, single nucleotide polymorphism (SNP) detection and haplotyping, providing genomic, polypeptide and protein information; generating genomes; pharmocogenomics, diagnostics and therapeutics pertaining to disease states and conditions

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, March 31, 2001
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 24, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateWednesday, May 24, 2000
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 24, 2000
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenome Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Party NameGenome Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events


Event DateEvent Description
Saturday, June 14, 2003ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 24, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2002PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2002NOTICE OF PUBLICATION
Sunday, January 27, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 2, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 3, 2001NON-FINAL ACTION MAILED
Wednesday, January 31, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 2, 2000UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Monday, July 31, 2000NON-FINAL ACTION MAILED
Tuesday, July 25, 2000ASSIGNED TO EXAMINER